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Cells of the monocyte/macrophage lineage, dendritic cells, and a  variety of 
other cell types that express class  II histocompatibility (Ia) molecules on their 
surfaces are capable of presenting foreign protein antigens to and stimulating Ia- 
restricted inducer (helper) T  lymphocytes (1-3). After the demonstration that B 
cells also bear Ia antigens (4) and that at least some interactions between antigen- 
specific helper T  cells and B lymphocytes are Ia restricted (5), many investigators 
have attempted to determine whether B lymphocytes  can also function as antigen- 
presenting cells. Among the earliest studies to demonstrate that B cells can, in 
fact, present antigens to T  cells were the experiments showing that macrophage- 
depleted murine B cells incubated with protein antigens could stimulate immune 
T  lymphocytes to proliferate in  an  Ia-restricted fashion (3).  More convincing 
evidence for  the  role  of B  cells  in  presenting antigen  came from studies  of 
Chesnut and Grey (6),  who showed that macrophage-depleted splenocytes cul- 
tured with rabbit anti-mouse immunoglobulin (Ig), but not rabbit IgG lacking 
anti-Ig activity, could stimulate rabbit 3,-globulin-primed T  cells to proliferate in 
vitro (6). This result not only established the ability of B lymphocytes to present 
protein  antigens  to  T  cells but  also  indicated that  their  surface Ig receptors 
played an important role in this phenomenon. Subsequently, it has been shown 
that resting and mitogen-activated normal B lymphocytes as well as a variety of 
Ia-positive B cell-derived tumors and cell lines are capable of presenting foreign 
proteins  to  Ia-restricted,  antigen-reactive T  lymphocytes (7-12).  In  all  these 
situations, high concentrations of antigens are required and surface Ig receptors 
play no role. In fact, the amounts of antigens required for such presentation are 
comparable to those observed with other accessory cells (1, 2), but in vast excess 
of the concentrations required  for T  cell-dependent, antigen-specific,  major 
histocompatibility-restricted activation  of primed  B  lymphocytes (13).  Thus, 
although  cloned  B  cell  tumors  and  normal  B  lymphocytes are  valuable  for 
analyzing the cellular and molecular events in antigen presentation (e.g., 14,  15), 
the relevance of such  studies  to  physiologic antigen-specific T-B  interactions 
involving cognate recognition of linked antigenic determinants is unclear. 
In  an  attempt  to  develop  systems  for  analyzing  the  interactions  between 
antigen-specific T  and B lymphocytes, we have investigated the ability of B cells 
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enriched  for  expression  of surface  receptors  for a  defined hapten  to  present 
hapten-protein  to  carrier-specific  T  cells.  In  the  initial  experiments,  primed 
murine  B  lymphocytes specific  for  2,4,6-trinitrophenyl  (TNP) 1 were  used  to 
present a  TNP-modified,  Ir  gene-controlled synthetic terpolymer of glutamic 
acid, lysine, and phenylalanine (GLib) to a GLib-reactive T  cell hybridoma. Such 
cloned hybridoma cells, which secrete interleukin 2 (IL-2) upon interaction with 
the relevant nominal antigen and Ia determinant, have been extensively charac- 
terized and are  widely used  to analyze the requirements  for T  cell  activation 
(16-17).  Our experiments demonstrate that hapten-specific B  lymphocytes are 
highly efficient at presenting hapten-protein to T  cells, and that hapten-binding 
surface Ig molecules are critically involved in this effective form of T-B interac- 
tion. Moreover, in this system it appears that the major role of surface Ig is to 
concentrate or "focus" antigen on to relevant B cells such that very low concen- 
trations of antigen are able to maximally stimulate the responding T  lymphocytes. 
The results also raise  the possibility that antigen-binding B  cells may serve an 
important role as antigen-presenting cells in physiologic immune responses. 
Materials and Methods 
Mice.  BALB/c mice, ages 6-12  wk, were purchased from Charles River  Breeding 
Laboratories, Inc., Kingston, NY or Cumberland Farms, Clinton, TN. Animals used in 
this study were maintained in accordance with the guidelines of the Committee on Animals 
of the Harvard Medical School and those prepared by the Committee on Care and Use 
of Laboratory Animals of the Institute of Laboratory Animal Resources, National Re- 
search Council (DHEW Publication No. (NIH) 78-23,  revised 1978). 
Antigens  and  Antibodies.  Hapten  conjugates  of GL4~, keyhole limpet  hemocyanin 
(KLH), human serum albumin (HSA),  bovine 3~-globulin (BGG), and lipopolysaccharide 
(LPS) were prepared by incubating the carriers with 2,4,6-trinitrobenzene sulfonic acid 
(TNBS) at pH 9-9.5 for 4-6 h, and removing unbound TNBS by dialysis or gel filtration. 
Rabbit anti-mouse Ig was prepared  from a  hyperimmune rabbit anti-mouse F(ab')2 
serum by affinity chromatography on mouse 3,-globulin-coupled  Sepharose 4B, digested 
with pepsin, and the F(ab')2  fragment purified by passage  over protein A-Sepharose. A 
control normal rabbit F(ab')2  was prepared from rabbit serum absorbed with mouse 3,- 
globulin. The following anti-TNP mouse sera were used: hyperimmune BALB/c anti- 
TNP-KLH serum and sera from mice immunized 2-6 wk previously with TNP-KLH in 
complete Freund's adjuvant and used as donors for B cells (see below). All these sera were 
heat inactivated and shown to have TNP binding activity at dilutions > 1:106 in a sensitive, 
solid phase radioimmunoassay using TNP-bovine albumin-coated microtiter plates.  In 
addition, two  monoclonal anti-TNP  antibodies were  used:  an  IgGl,x (termed  HDPI; 
provided by Dr. H. Urnovitz and Dr. R. Lynch, University of Iowa) and an IgM,~ (termed 
T2.8), prepared by fusion of TNP-Ficoll-immunized BALB/c spleen cells. Both of these 
showed anti-TNP  activity at titers >1:102  in  the solid phase  radioimmunoassay. The 
following monoclonal anti-Ia antibodies were  used  in  blocking experiments at  a  1:8 
dilution of hybridoma culture supernatant: MKD6 (18) (anti-I-A a) and 14.4.4s (19) (anti- 
I-Ed). 
Hapten-specific  B Lymphocytes.  Spleen cells were obtained from BALB/c mice immu- 
nized 6 d previously with 0.5 ~g of TNP-LPS in aqueous solution intraperitoneally (i.p.) 
1 Abbreviations used in this paper:  BGG, bovine 3,-globulin;  GAT, random terpolymer of glutamic 
60  30  10  56  $5  acid  ,  alanine  ,  and  tyrosine  ;  GLqS, random  terpolymer  of  glutamic  acid  ,  lysine  ,  and 
phenylalanineg; HSA, human serum albumin; IL-2, interleukin 2; KLH, keyhole limpet hemocyanin; 
LPS, E.  coli lipopolysaccharide; MEM, minimum essential medium with 5% heat-inactivated fetal calf 
serum;  MHC, major histocompatibility complex; TNBS, 2,4,6-trinitrobenzene  sulfonic acid; TNP, 
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or 2-6  wk  previously with  100  #g  of TNP-KLH in  complete Freund's adjuvant  i.p. 
Hapten-binding B cells  were purified by a  modification of the technique of Haas and 
Layton (20). Erythrocyte-free spleen cells were suspended in minimum essential medium 
with 5% heat-inactivated fetal calf serum (MEM) and incubated on 100-mm plastic culture 
dishes coated with TNP-gelatin, at a ratio of 100-150 X 108 cells in 5 ml per dish. Dishes 
were rocked gently at 4°C for 60 min, washed five times with ice-cold MEM, and bound 
cells eluted by adding 5 ml of MEM warmed to 37°C. Cells were treated with t00 U/ml 
of collagenase (Worthington Biochemical Corp.,  Freehold, NJ) for 15 min at  37°C to 
remove bound TNP-gelatin, washed three times, and viable cell recovery determined by 
trypan blue dye exclusion. In our hands, 0.5-1.5% of input splenocytes were recovered 
from TNP-gelatin dishes;  50% of these cells expressed surface Ig by immunofluorescence 
and 20-40% have detectable TNP receptors as determined by rosette assays with TNP- 
coupled sheep erythrocytes. Both these assays may underestimate the number of hapten- 
specific cells because of receptor modulation during the purification procedure. After 4 
d  stimulation  with  LPS  in  vitro,  the  TNP-gelatin-enriched cells  show a  50-100-fold 
enrichment of anti-TNP antibody-secreting cell precursors (on a per cell basis) compared 
with the initial, unpurified splenocyte population. The cells eluted from hapten-gelatin 
are referred to as hapten-specific B lymphocytes in the following sections. 
T Cell Hybridomas.  RF21.21.9 was obtained from the fusion of BALB/c GL~immune, 
antigen-restimulated, proliferating T  cells to the AKR thymic lymphoma, BW 5147, as 
previously described (17). It produces IL-2 when stimulated with GLib in association with 
I-E  d. This response is exquisitely antigen specific and H-2 restricted (K. L. Rock and B. 
Benacerraf, manuscript in preparation). RF7.24.3 is a BALB/c, I-A  n + GAT-specific, IL- 
2-producing T cell hybridoma that was similarly derived (21). 
Cell Culture and Assay Conditions.  Culture media was RPMI 1640 (M. A. Bioproducts, 
Walkersville, MD) supplemented as previously described (21).  5-7.5 ×  104 T  cell hybri- 
domas were cultured in 200-#1 flat-bottom microcuitures with or without accessory cells, 
in the presence or absence of antigen and in some cases antibody. The source of accessory 
cells was either hapten-specific, unirradiated B cells, irradiated (1,600 rad) or unirradiated 
whole spleen cells, or the in vitro passaged, cloned B lymphoblastoid tumor, A20.2J (16). 
The precise numbers of accessory cells and the concentration of antigen or antibody are 
detailed in the respective experimental protocols. After 18-24 h incubation at 37 ° C, 100 
~tl of culture supernatant was removed, exposed to 8,000 rad gamma irradiation, and 
assayed for IL-2 content. IL-2 was measured by quantitating the incorporation of [3H]- 
thymidine into DNA of an IL-2-dependent T cell line, HT-2, in response to this lympho- 
kine (I 8, 21). Data are expressed as the arithmetic mean counts per minute of duplicate 
cultures. 
Results 
Presentation of Hapten-modified Antigen by Hapten-specific B  Cells.  In the first 
series of experiments we compared the ability of TNP-specific BALB/c (H-2  d) B 
lymphocytes to present GLib and TNP-modified GL~ to the GLC~-specific, I-E  d- 
restricted T  cell hybridoma, RF21.21.9. As shown in Fig.  1, such hapten-specific 
B lymphocytes were capable of presenting the TNP-protein at a <10-fold lower 
concentration  than  the  unmodified  protein.  A  more  detailed  analysis  of the 
antigen concentrations and presenting cell numbers required to activate the T 
cell hybridoma is shown in Figs. 2 and 3. Hapten-specific B cells presented TNP- 
GL~ at concentrations as  low as  0.1  #g/ml,  and  as  few as  7  ×  10 s cells were 
effective at presenting haptenated  protein.  It  is noteworthy that  with  2  ×  105 
TNP-specific B cells, TNP-GL~ at 0.1  #g/ml, which is the lowest concentration 
we  have  tested,  produced  >70%  of the  maximal  T  cell  response  (Fig.  2).  In 
contrast, the same B cells presented unmodified GLib only at high concentrations 
(100 #g/ml) and relatively high cell numbers (2 x  105).  Thus, hapten-specific B ROCK,  BENACERRAF,  AND  ABBAS  1105 
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FIGURE  1.  Comparison of hapten-specific B cell antigen presentation of native and hapten- 
conjugated GL~. Microcultures were prepared with 5 x  104 RF21.21.9 T  cell hybrid and 6 x 
105 TNP-binding B cells in the presence or absence of indicated amount of antigen (O, TNP- 
GLq~; Q, GL4~) in 200 t~l. After 18 h incubation,  100 #1 of culture supernatant was removed, 
irradiated, and assayed for IL-2 content. Control experiments have shown no detectable IL-2 
in cultures of B cells plus antigen, in the absence of specific T  cell hybrids (data not shown). 
Hapten-specific B cells were isolated from TNP-LPS-primed mice. 
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FIGURE 2.  Comparison  of hapten-conjugated antigen presentation by antigen-specific and 
naive B cells.  Microcultures were prepared as described in Fig.  1 except that the source of 
antigen-presenting cells was varied: (A) 2 ×  105 TNP-binding B cells from TNP-LPS-primed 
mice; (B)  105 A20 B-lymphoblastoid cells (  ) or 2  ×  10~unirradiated,  naive splenocytes 
(_ _ _). Both A and B are from the same experiment. 
cells presented the haptenated antigen >l,000-fold more efficiently than  the 
unmodified antigen. This effect was hapten specific,  since GL4~ modified with 
other haptens, such as fluorescein, was presented by TNP-specific B cells like the 
unhaptenated protein (data not shown). Moreover, TNP-GL4~ was not intrinsi- 
cally more immunogenic than GL4~, as both A20.2J B lymphoma cells and naive, 
unpurified splenocytes (Fig.  2) showed no difference in their ability to present 
the two antigens. Both of these accessory cell populations required high concen- 
trations of antigen (10-100  ~g/mi), which was precisely the concentration of 
unhaptenated antigen required by hapten-specific B cells (Figs. 1 and 2). Controls 
done with these and subsequent experiments showed that in the absence of either 1106  ANTIGEN  PRESENTATION  BY  B  CELLS 
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FIGURE 3.  Titration of the number of TNP-specific  B cells  required for antigen presentation. 
Microcultures were prepared as described in Fig. 1, with the indicated number of TNP- 
binding B cells and the presence or absence  of the indicated concentration of TNP-GL~. This 
data was obtained from the same experiment illustrated in Fig. 9. 
antigens or presenting cells, the T  cell hybridoma was not stimulated to produce 
IL-2. Furthermore,  the hapten-specific B ceils alone did not produce IL-2 upon 
challenge with TNP-GL4~ or GEqL as expected (data not shown). Identical results 
were obtained with B cells from TNP-LPS- and TNP-KLH-primed mice. 
I-E Restriction of Antigen Presentation  by B Lymphocytes.  Monoclonal antibody 
blocking  experiments  were  done  to  determine  the  major  histocompatibility 
complex (MHC) restriction of antigen presentation by hapten-specific B cells. As 
shown  in  Table  I,  stimulation  of  the  I-Ed-restricted  T  cell  hybridoma  by 
BALB/c TNP-specific B cells and TNP-GL~b was markedly inhibited by mono- 
clonal anti-LE d relative to anti-I-A d antibody. This effect was specific, since both 
antibodies bind to the presenting  cells, and the reciprocal pattern of inhibition 
was  observed  with  I-An-restricted  T  cell  hybridomas.  The  same  pattern  of 
inhibition was seen with either TNP-specific B lymphocytes or A20.2J cells and 
high concentrations of unmodified GLq~ (data not shown). 
Role of Hapten-binding  Ig Receptors in Antigen Presentation.  The above exper- 
iments indicated that cell populations enriched for hapten-specific B iymphocytes 
were  also  markedly  and  selectively  enriched  for  cells  capable  of presenting 
hapten-modified proteins to Ia-restricted T  cells. To establish a role for surface 
Ig in this phenomenon,  attempts were made to block antigen presentation  with 
ligands that would be expected to bind to receptors for the hapten.  As shown in 
Table II, preincubation of TNP-specific B cells with affinity-purified rabbit anti- 
mouse Ig completely blocked the ability of these cells to present TNP-GL4~ to 
the T  cell hybridoma, RF21.21.9, and TNP-conjugated HSA or BGG inhibited 
the presentation of TNP-GL4~ by 80-90%. Unhaptenated proteins (Table II) or 
rabbit Ig (data not shown) had no effect. This inhibition was highly specific, since 
the anti-Ig and TNP-proteins did not interfere with the ability of the same TNP- 
specific B cells to present GLq~ at high concentrations, despite the response being ROCK,  BENACERRAF,  AND  ABBAS 
TABLE  I 
Effect of Monoclonal a-Ia Antibody on Antigen Presentation of TNP- 
GL~ 
2 ×  l05 TNP-  Monoclonal 
Hybrid  B cells  Antigen  antibody  cpm 
RF21.21.9 
RF7.24.3 
tag/ml 
+  --  --  2,981 
+  10 GLq5  --  2,564 
+  1 TNP-GL~  --  35,289 
+  1 TNP-GLq~  I-E  a  4,911 
+  1 TNP-GLq~  I-A  d  15,863 
+  --  --  2,722 
+  100 GAT  --  23,964 
+  100 GAT  1-E  a  16,262 
+  100 GAT  I-A  a  3,588 
Microcultures were prepared as described in Fig. 1, except 2 × 105 TNP- 
binding B cells were used  and a  1:8 dilution of monoclonal antibody- 
containing culture supernatant was added where indicated. RF7.24.3 is a 
GAT + I-Aa-specific  T cell hybrid included as a reciprocal control. TNP- 
specific cells were obtained from TNP-LPS-primed mice. a-I-E  a, 14.4.4.S; 
a-I-A  a, MKD6. 
1107 
substantially  weaker.  Moreover,  none  of the  inhibitors  affected the  ability  of 
non-TNP-binding A20.2J B cells to present the same antigen, TNP-GL~b (Table 
II). These results demonstrate that the augmented presentation of TNP-protein 
by TNP-binding B cells is specific for the hapten and not the carrier, and directly 
implicate B cell Ig in this highly efficient presentation of haptenated antigen. 
Function  of lg Receptors  in Antigen  Presentation.  There are several,  not mu- 
tually exclusive, reasons why hapten-binding B lymphocytes might be particularly 
efficient at presenting haptenated antigen to Ia-restricted T  cells. The simplest 
is  that  Ig  receptors  serve  to focus antigen,  and  perhaps  direct its  pathway  of 
endocytosis  and  processing.  Alternatively,  the  binding  of antigen  to  surface 
receptors may deliver a  signal(s) that activates target B  lymphocytes to become 
more efficient at presenting antigen; such activation events may include enhanced 
expression of Ia determinants (22-24).  To test this possibility, TNP-specific B 
cells with and without TNP-GLq~ were compared for their ability to stimulate a 
T  cell  hybridoma specific for an  unrelated,  unmodified  protein,  GAT  (a  ter- 
polymer of glutamic acid  66, alanine s°, and tyrosine ~0), or to stimulate an alloreac- 
tive T  cell hybridoma. As shown in Table III, the continuous presence of TNP- 
GL4~ at a  concentration at which  it was effectively presented did not alter the 
ability of TNP-specific B cells to present GAT to a  GAT +  I-Ad-specific T  cell 
hybridoma.  Similarly, TNP-GL4~ did  not make  the  TNP-specific B  cells more 
efficient  stimulators  of an  allogeneic  I-Ea-reactive  T  cell  hybridoma.  This  is 
particularly  relevant since  I-E  a  is  the  restriction  element of the  GL~-reactive 
hybrid, RF21.21.9.  Finally, the presence of TNP-conjugated HSA or BGG did 
not activate the  hapten-specific  B  cells to more efficiently present unmodified 
GL4~ to RF21.21.9, as they would TNP-GL~b (Table II). Therefore, the interac- 
tion of TNP-conjugated antigens with the B cells fails to markedly enhance their 
ability to present unhaptenated antigens in a noncognate manner. 1108  ANTIGEN  PRESENTATION  BY  B  CELLS 
TABLE  II 
Hapten- and Immunoglobulin-specific Blocking of TNP-GL¢~ Presentation by Specific B Cells 
Antigen-present-  Antigen (#g/ml)  Inhibiting antigen/  cpm  Percent 
Hybrid  ing cells  Ab (#g/ml)  inhibition 
RF21.21.9  2 x  105 TNP-B  --  --  1,051 
2 X 105 TNP-B  0.3 TNP-GL4~  --  49,206 
50 RAMG F(ab')~  1,257  100 
10O  TNP-HSA  7,428  88 
100  HSA  52,768  0 
100 TNP-BGG  8,806  84 
100  BGG  48,781  1 
2 x  105 TNP-B  100 GL~  --  5,345 
50 RAMG F(ab')2  9,623  0 
100 TNP-HSA  13,054  0 
100  HSA  4,134  28 
100 TNP-BGG  5,356  0 
100  BGG  4,492  20 
2 x  105 TNP-B 
m 
m 
m 
B 
50 RAMG F(ab')2  1,412 
100 TNP-HSA  2,051 
10O  HSA  1,305 
100 TNP-BGG  2,198 
100  BGG  1,254 
RF21.21.9  105 A20  1,801 
105 A20  25 TNP-GL4~  --  68,831 
50 RAMG F(ab')2  66,470  0 
100 TNP-HSA  47,534  31 
100  HSA  58,948  14 
100 TNP-BGG  68,190  0 
100  BGG  77,160  0 
Microcultures were prepared as described in Table I except for the addition of the indicated amount 
of rabbit anti-mouse Ig (RAMG) F(ab')2 or competing antigen. These potential inhibitors were 
incubated with B cells at 37°C for 60 min before the addition of hybrids, and were continuously 
present throughout the remainder of the culture. Data from one representative experiment out of 
two are shown.  In the second experiment, RAMG F(ab')~ inhibited presentation of TNP-GL$ by 
TNP-specific B cells by 100%, while normal rabbit F(ab'), had no effects. 
It  is  possible  that  TNP-specific,  immunized  B  lymphocytes  secrete  small 
amounts  of antihapten  antibody that complexes with and augments  the presen- 
tation  of hapten-protein.  To  test  this  possibility, A20.2J  cells  were  incubated 
with TNP-GL$  at a  suboptimal concentration, with and without a  wide range of 
dilutions of four different anti-TNP  antibodies (two  sera and  two  monoclonals 
both  IgG and  IgM),  and  the  IL-2 response  of the  RF21.21.9  hybridoma  mea- 
sured. None of the antibodies tested altered the presentation of TNP-GL$  under 
these conditions (Table IV). 
Discussion 
The experiments reported in this paper were designed to examine the ability 
of antigen-binding B lymphocytes to present the specific antigen to Ia-restricted ROCK,  BENACERRAF,  AND  ABBAS  1109 
TABLE  III 
Haptenated Antigen Does Not Augment Antigen or MHC Molecule Presentation in a 
Noncognate Manner 
Hybrid specific-  TNP-B cells  Antigen (#g/  TNP-GL4~ (1  cpm 
Hybrid  ity  (×  10  ~)  ml)  #g/ml) 
RF7.24.3  GAT +  I-A  d  2  --  -  2,722 
2  10 GAT  -  18,549 
2  1 GAT  -  8,047 
2  I  GAT  +  5,132 
RF26.12  I-E  d (Allo)  --  --  -  3,486 
1  --  -  33,840 
0.5  --  -  31,074 
0.25  --  -  15,042 
0.125  --  -  8,064 
0.075  --  -  5,502 
1  --  +  36,233 
0.5  --  +  26,184 
0.25  --  +  23,129 
0.125  --  +  10,565 
0.075  --  +  6,313 
Microcultures were prepared as described in Table I except using the RF7.24.3 and RF26.12 hybrids 
and  the  corresponding antigen  to  RF7.24.3,  GAT.  Data  was obtained  for  the  same  experiment 
illustrated in Table I, demonstrating that  1 #g/ml of TNP-GLq~ was presented strongly in a  cognate 
manner. 
TABLE  IV 
Anti-TNP Antibody Does Not Enhance the Presentation of TNP-GL4~ 
Antigen-present-  Antigen (~g/ml)  Antibody*  cpm 
Hybrid  ing cells 
RF21.21.9  TNP-B cell  --  --  312 
10 GLq~  --  268 
1 TN P-GL4~  --  9,299 
A20 
100 TNP-GLq~ 
33 TNP-GL~ 
10 TNP-GLq~ 
1 TNP-GLff 
A20  1 TNP-GLO 
--  347 
--  13,520 
--  1,782 
--  343 
--  1,046 
1:10  -4 hyperimmune serum  816 
I:10 -5 byperimmune serum  669 
1:10  -3 donor serum  638 
1:10  -s donor serum  693 
1:4 T2.8 MAb  964 
1:8 T2.8 MAb  871 
1:4 HDPx MAb  627 
1:8  HDPI  MAb  633 
Microcultures were prepared as described in Table I except that either 2.5 ×  10  ~ TNP-B cells from 
TNP-KLH-primed  mice  or  5  ×  104  A20  cells  were  used and  the  indicated  source  of anti-TNP 
antibody was added. 
* Donor serum was serum obtained from the immune B cell donors. MAb, monoclonal antibody. 1110  ANTIGEN PRESENTATION BY  B CELLS 
T  cells. Using a  model system in which TNP-primed B lymphocytes, enriched 
for hapten-binding cells, were used to present a TNP-modified protein, GL~, to 
a GL¢-reactive, I-Ed-restricted T  cell hybridoma, we have observed that such B 
cells are remarkably efficient antigen-presenting cells. Hapten-specific B lympho- 
cytes were capable of activating the T  cell hybridoma in the presence of soluble 
hapten-protein at 100 ng/ml, which is a lower antigen concentration for effective 
presentation to T  cells than has been described in any in vitro system, to date. 
Moreover, as few as 7  ×  l0 s hapten-enriched cells were sufficient to stimulate 
the relevant T  cell hybridoma. Considering the low numbers of hapten-specific 
B lymphocytes that are effective at presenting antigen, it is likely that these cells 
alone are sufficient for stimulating  the  T  cell  response.  Recent  experiments 
(work in progress) using transformed, antigen-specific B cell clones support this 
interpretation. However, it should be pointed out that the question of whether 
other cell types present in  the hapten-enriched population  also play a  role in 
activating T  lymphocytes has not been addressed by our experiments. 
Several  lines  of evidence demonstrated a  central  role  of surface Ig in  the 
presentation of hapten-protein by hapten-specific B cells.  First, TNP-specific B 
cells presented low concentrations of TNP-GLq~ but not unmodified GL¢ (Fig. 
2) or fluorescein-conjugated GL4~ (not shown) to the same GL¢-reactive T  cell 
hybridoma. Second, the presentation of TNP-GL4~ by the B cells was specifically 
inhibited by anti-lg antibody and by other TNP-modified proteins (Table II). In 
this respect, our observations are fundamentally different from most results of 
antigen presentation by B lymphocytes. Thus, resting, activated, and neoplastic 
B cells are capable of presenting protein antigens to Ia-restricted T  cells (6-12), 
but in all  these cases Ig receptors play no role.  The only situation in which a 
function for B cell Ig in antigen presentation has been demonstrated is the study 
of Chesnut and Grey (6)  showing that  rabbit anti-Ig is presented by partially 
purified B cell populations under conditions where normal rabbit Ig is not. Even 
in  these  experiments,  however,  high  concentrations of protein  antigen  were 
required, comparable to  the concentrations at  which effective presentation  is 
observed with other accessory cells such as macrophages and dendritic cells. 
It has been postulated that Ig receptors on B lymphocytes may serve at least 
two functions relevant to the ability of these cells to present antigens to T  cells. 
The most obvious is that receptors focus antigen on the cell surface and lead to 
a  sequence of endocytosis and processing that culminates in  the expression of 
antigenic determinants in association with Ia molecules. In addition, the antigen- 
receptor interaction may activate B cells to a state at which they are efficient at 
antigen presentation;  such activation may include enhanced expression of Ia, 
more efficient antigen processing, and other, as yet undefined, changes in the 
physiologic properties of the cells (22-24).  In our experiments, TNP-GL¢ did 
not enhance the ability of TNP-specific B cells to present an unrelated, nonhap- 
tenated protein or to stimulate alloreactive T  cell hybridomas (Table III), and 
the enhanced presentation  always required  linked  or  cognate recognition  of 
hapten-carriers by carrier-specific T  cell hybridomas.  Moreover, there was no 
evidence that antibody secretion could account for the ability of these cells to 
present TNP-protein  (Table IV).  Therefore, by exclusion, it is likely that  the 
only or major role of surface Ig in antigen presentation by B cells is to bind and ROCK,  BENACERRAF,  AND  ABBAS  1111 
focus the specific antigen.  It should be emphasized that the B cells used in the 
present experiments were obtained from primed animals and were,  therefore, 
previously  activated.  It  is  certainly  conceivable  that  in  resting  B  cells,  the 
activation induced by antigen-receptor interactions plays a  more important or 
readily demonstrable role in antigen presentation. In any event, it is likely that 
antigen  binds  to  surface  Ig and  is  endocytosed and  degraded  by  proteolytic 
enzymes; such a sequence of events has been demonstrated with anti-Ig antibodies 
(25).  Thus,  in  general,  the  cellular  processes leading  to  Ia-associated  antigen 
presentation may be similar in B  lymphocytes and in more intensively studied 
antigen-presenting ceils, such as monocytes/macrophages and possibly dendritic 
cells (1, 2). 
The ability of B cells to present nominal protein antigens to inducer T  cells 
has several  implications for physiologic immune responses.  It may provide an 
accessory cell-independent mechanism for stimulating inducer cells to secrete 
helper factors that are necessary for clonal expansion and differentiation of B 
lymphocytes. The critical role of surface Ig in this phenomenon suggests that B 
cells are most efficient at presenting the antigen for which they express specific 
membrane  receptors.  This  provides  an  explanation  for  the  observation  that 
physiologic cognate T-B collaboration occurs at concentrations of antigens that 
are insufficient to cause detectable activation of helper T  cells in conventional in 
vitro assays for DNA synthesis in which antigen is presented by macrophages or 
dendritic  cells.  Furthermore,  it  would  account  for  the  finding  that  in  most 
antibody responses  in  vivo,  activation  of bystander  B  cells  is  rarely  or  never 
observed. This may also explain, at least in part, the stringent MHC restriction 
of T-B interactions observed in vivo and in secondary antibody responses to low 
dose antigen challenge in vitro (5, 26). 
Finally, our finding that B cells present antigens at concentrations approaching 
expected physiologic levels suggests  that  such  cells  may play a  major  role  in 
presenting  antigen,  at  least  to  previously  activated  T  lymphocytes,  in  vivo. 
Whether,  in  addition  to  this  ability  to  present  antigen  in  association  with  Ia 
molecules, B cells produce secondary activation signals, e.g., interleukin 1, is not 
known (17).  Such antigen-nonspecific cytokines may be important for the acti- 
vation of naive or resting T  lymphocytes. Thus,  it  remains to be determined 
whether  or  not  B  lymphocytes are  also  capable  of initiating  antigen-specific 
immune responses, i.e., by stimulating normal, resting inducer T  cells. 
Summary 
The present  study examines the ability  of hapten-specific murine splenic  B 
lymphocytes to  present  hapten-proteins  to  carrier-specific  T  cell  hybridomas. 
BALB/c B cells specific for 2,4,6-trinitrophenyl (TNP) were isolated from spleens 
of immune mice by elution from TNP-gelatin-coated dishes. Such cells presented 
the TNP-modified terpolymer, GL4~, at concentrations as low as 0.1 /~g/ml, to a 
GL4~-specific,  I-Ed-restricted,  interleukin  2-producing  T  cell  hybridoma.  In 
contrast, the same B lymphocytes required  1,000-fold higher concentrations of 
unmodified GLq~ to stimulate the same T  cell hybridoma. The presentation of 
low concentrations of TNP-GLq~ by TNP-specific B lymphocytes was significantly 
or  completely  blocked  by  anti-Ig  antibody  or  TNP-proteins,  indicating  that 1112  ANTIGEN  PRESENTATION  BY  B CELLS 
surface Ig receptors were critically involved in this phenomenon. Finally, binding 
of TNP-proteins  did  not  alter  the  ability of the  B  cells  to  present  unrelated, 
unhaptenated proteins or to stimulate alloreactive T  cells. These results suggest 
that surface Ig receptors serve to focus antigens onto specific B lymphocytes and 
that such cells are highly efficient at presenting linked antigenic determinants to 
T  cells.  The implications  of these  findings for the  mechanisms of physiologic, 
histocompatibility-restricted T-B collaboration are discussed. 
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